July 24, 2008 - The FDA has granted clearance for GE Healthcare’s newest positron emission tomography/computed tomography (PET/CT) scanner, which is part of GE’s Discovery family of scanners designed to enable earlier detection and monitoring of disease with advanced molecular imaging technology in both hardware and software.

July 24, 2008 - FluoroPharma said it achieved positive phase I test results for BFPET, a novel Fluorine-18 labeled tracer for PET myocardial perfusion imaging.

BFPET is designed to assess the blood flow in the heart (myocardial perfusion), which is a standard test to assess coronary artery disease (CAD), with more than 9 million Americans undergoing the test annually.

July 24, 2008 – Covidien recently launched the Optistar Elite contrast delivery system, designed to inject contrast media-related drugs into a patient’s vascular system to aid in obtaining diagnostic images when used with magnetic resonance (MR) imaging equipment.

The product recently received FDA approval and already carries a CE Mark.

The Optistar Elite aims to provide improved performance and ease of use, compared with the previous Optistar LE model.

Philips has a new addition to its HD ultrasound family of products, the Philips HD15 ultrasound system, which is designed to provide physicians with high-end imaging and workflow performance in a cost-effective system.

EKOS Corp. offers the EkoSonic Endovascular System (EkoSonic).

The design includes an advanced control unit with an easier, more intuitive user interface, making set up and operation simple. EkoSonic ES is also compatible with a new line of endovascular devices, EkoSonic Mach 4 Endovascular Device. The Mach 4 was specifically created to be compatible with the RPM technology.

July 23, 2008 - EKOS Corp.’s EkoSonic Endovascular System (EkoSonic ES) with Rapid Pulse Modulation (RPM) for the dissolution of vascular blood clots, reportedly represents the only endovascular system that can deliver microsonic energy and thrombolytic drugs simultaneously, providing a safer, faster and more complete way to remove clots by accelerating dissolution.

July 23, 2008 – A recent study found intensive LDL-cholesterol lowering with the combination of the drugs simvastatin and ezetimibe in patients with mild to moderate aortic stenosis does appear to reduce the risk of coronary artery disease events, but does not slow the rate of progression of aortic valve disease.

The study also showed a possible link between these drugs and an increased cancer risk.

July 23, 2008 - Independent research institutions will put the CardiArc SPECT system from CardiArc Inc, Southfield, MI, to the test. Both Cleveland Clinic, Cleveland, and Emory University, Atlanta, will evaluate the performance and design of the cardiovascular camera in clinical settings.

The unit is designed specifically for cardiac imaging, particularly for coronary artery disease detection. SPECT, or single photon emission computed tomography, noninvasively creates 3D images that show the blood flow and function of major organs, such as the heart.

July 23, 2008 – Ventricular-assist devices (VADs) are getting smaller, more reliable and may someday eliminate the need for heart transplants, say doctors at the University of Michigan.

July 23, 2008 — Vascular Solutions, Inc. recently launched the Axis Wire, a 0.035-inch specialty guidewire that combines an extra stiff proximal shaft with a long super-floppy distal tip.

Subscribe Now